Prominent emerging markets investor Mark Mobius said he would "definitely" be interested in putting money into North Korea if he could.
Chi Lo of BNP Paribas explains how China's economy is being affected by its old and new sectors growing at different speeds.
Media companies are joining forces to take on digital streaming services.
High market valuations are a cause for concern, an investment manager has warned.
A report from UBS says millennials could be worth $24 trillion by 2020, beat baby boomers in launching new businesses.
Aetna CEO Mark Bertolini tells CNBC he’s moving Aetna’s headquarters from Hartford, Connecticut in order to attract more tech savvy and innovative young talent. Founded in Hartford more than 160 years ago, Aetna currently employees more than 6,000 people in Connecticut.
The world’s shipping players have a vested interest in preserving free global trade, and they’ve grown unsettled by rising protectionism.
The euro may have taken a beating from a strong dollar and Europe's political risks, but now is the time to go long, a UBS analyst said.
Japan's largest IPO this year, Kyushu Railway, turned out to be just the ticket for yield-starved investors, taking the fast track higher on Tuesday.
Singapore has joined the influential International Energy Agency as an association country, upping the city-state's focus on energy security.
Weakening exports continued to dog the world's second-largest economy in August but imports were a bright spot.
CNBC's Bertha Coombs reports employees may now carry over up to $500 per year in their flexible spending accounts.
Running a medical device business requires understanding of the medical technology as well as the corporate environment, Uscom CEO Rob Phillips says.
Asian markets tumbled Monday as the region turned risk-off before the Brexit vote and key central bank decisions, with the Nikkei leading drops.
China clocked first quarter growth of 6.7 percent, after the stimulus measures of recent months finally took effect, economists said.
CNBC's Meg Tirrell provides insight to the debate over transparency from biotech companies. Biotech investor Brad Loncar, thinks this is just an awareness issue.
Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.
What's goes into the busiest day of travel in the U.S., with Gordon Bethune, former Continental Air CEO, who says a decline of last minute seats is driving current customer behavior.
The second open enrollment period which began over the weekend is the first time small businesses will be enrolling. CNBC's Kate Rogers reports the businesses will face a fine of $2,000 per worker, per year for failing to comply with the Affordable Care Act.